Promoting Influenza Vaccination In General Practice Waiting Rooms

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10597 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-15

Study Completion Date

2017-05-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Most of family physicians (FPs) use advertising in their waiting rooms in order to educate patients. Our objective was to assess an advertising campaign for influenza vaccination using posters and pamphlets in FPs' waiting rooms.

Registry based 2/1 cluster randomized controlled trial. Clusters gathered the listed patients over the age of 16 of 75 randomized FPs. The trial was conducted during the 2014-2015 influenza vaccination campaign. Intervention group, 25 FPs received and exposed in their waiting rooms pamphlets and one poster promoting the influenza vaccination campaign (added to the usual mandatory information). Control group (50 FPs), usual waiting room. The main outcome was the number of vaccination units delivered in pharmacies. Data were first extracted for 2013-2015 from the SIAM-ERASME claim database of the Health Insurance Fund of Lille-Douai (Northern France). The association between the intervention and the main outcome was assessed trough a generalized estimating equation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Enabling Family Physicians to Reduce Vaccine Hesitancy and Increase Covid-19 Vaccine Uptake

NCT04963790

Covid19 COVID-19 Vaccine

TERMINATED NA

Reducing Children's Distress Towards Flu Vaccinations

NCT01529021

Children's Distress During Flu Vaccination

COMPLETED

The Study Guide Cluster Randomized Control Trial

NCT03312218

Behavior

COMPLETED NA

Effectiveness of Pedialink CEASE Module

NCT01087177

Tobacco Use

COMPLETED NA

Patient Agenda Setting and Clinic Efficiency in Outpatients

NCT03433729

Respiratory Tract Diseases

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Every autumn the French National Health Insurance conducts a seasonal influenza immunization campaign. Since 2009, in France like in many other countries, the seasonal influenza immunization uptake has been decreasing in people over 65 years of age and in people with diverse target chronic diseases or pregnancy. It has remained far under the national and European objective of 75%. For this reason, public advertising has been intensified (TV, newspapers and magazines) and the involvement of health professionals was stimulated, particularly by means of encounters with Health Insurance delegates, and posters and pamphlets to be exposed in FPs' waiting rooms. We conducted a preliminary systematic review (in press) to seek for publications assessing the effect of audio-visual aids in primary health waiting rooms. It appears that most articles about this topic have a low level of evidence and that the effect on patient health behaviour has only been assessed on surrogate outcomes. The existence of an effect on behaviour change is controversial, and if any, it is small sized, needing more than 10,000 subjects to be demonstrated.

Our aim is to evaluate the effect of the advertising campaign using posters and pamphlets in FPs' waiting rooms on patients behaviour measuring the number of influenza vaccination units delivered in community pharmacies.

We designed a single blinded 2/1 registry based cluster randomized controlled trial.

The outcome is the number of seasonal influenza vaccination sets released in community pharmacies. The target population are patients over the age of 65 or having a chronic disease requiring seasonal influenza immunization (like chronic obstructive pulmonary disease (COPD) or diabetes). Patients are informed about the anonymous use of their data and can refuse to participate at any time.

A cluster is defined as the patients over the age of 16, who are registered by the Health Insurance on the participating FPs' patients' lists. A computerized random draw is used to allocate FPs in each group. In the intervention group, FPs will receive and expose in their waiting rooms 135 pamphlets and one poster (added to the usual mandatory information) withdrawing all the other posters. In the control group, waiting rooms are kept in their usual state. To evaluate the number of FPs needed for the trial, we set an interclass correlation coefficient of 0.02, for α = 5% and β = 20%. With a predicted rate of influenza vaccination delivery of 0.65 in the intervention group and 0.60 in the control group, and a target size by FP of 400 patients, 75 FPs have to be enrolled (50 in the control group and 25 in the intervention group).

Baseline is defined as the 2013-2014 vaccination campaign. Data are extracted between October 15, 2014 and February 28, 2015 from the SIAM-ERASME claim database of the Lille-Douai district Health Insurance Fund on patient level. To assess the association between the vaccination status (dependent variable) and the group intervention/control, because of the hierarchical structure of the data and the high incidence rate of the main outcome, we will use a generalized estimating equation (GEE) Poisson regression clustering by GP; an exchangeable working correlation matrix will be used. The analysis will be carried out using R software (version 3.3.1) and the package Geepack.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Behavior Vaccination Influenza, Human

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Registry based cluster randomized trial. The population was the patients aged over 16 of 75 FPs, with an indication for seasonal influenza immunization (pregnancy, long lasting disease, age over 65). The main outcome is the proportion of vaccinated patients, based on the number of vaccination units dispensed in community pharmacies. This number is retrieved from the SIAM-ERASME claim database of the Lille-Douai Health Insurance Fund.

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Patients were identified by a number

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Family physicians' patients exposed to advertisement in waiting rooms consisting in a poster and pamphlets promoting seasonal influenza vaccination (+ usual mandatory information)

Group Type EXPERIMENTAL

Control group

Family physicians' patients exposed to usual laying out of waiting rooms

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Advertising, poster, pamphlets

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients aged 65 years and more
* Pregnant women
* Patients with a chronic long lasting disease needing yearly seasonal influenza immunization

* respiratory diseases: COPD, emphysema, asthma, silicosis, Bronchial dilatation, cystic fibrosis, other respiratory diseases at risk of influenza complications
* cardiovascular diseases: Congenital heart disease, heart failure, valvulopathy, rhythm disorder, coronary heart disease, stroke, infarction, coronary bypass
* neurologic diseases: Myopathy, multiple sclerosis, sequelae of stroke, dementia (Alzheimer or others), poliomyelitis, gravis, paraplegia or tetraplegia reaching the diaphragm
* kidney and liver diseases: severe kidney failure, nephrotic syndrome, chronic hepatitis, cirrhosis
* metabolic disorders: diabetes, malignant obesity
* immunity disorders and blood diseases: cancer and other malignant diseases, organ and marrow transplantation, immune deficiency, Inflammatory and autoimmune diseases with immunosuppressive medication, HIV infection, sickle cell disease.